Table 3 Comparisons of complications and outcomes between LDA and control groups

Hypertensive disorders

26 (11.1)

40 (17.0)

0.65 (0.41–1.03)

Gestational hypertension

15 (6.38)

17 (7.23)

0.88 (0.45–1.73)

PE

11 (4.68)

23 (9.79)

0.48 (0.24–0.95)

DC

9

17

–

MC

2

6

–

PE < 34 weeks

0

1

–

PE < 37 weeks

7

18

0.39 (0.17–0.91)

PE ≥ 37 weeks

4

5

0.80 (0.22–2.94)

Neonatal weight (mean)

2550 (2280–2780)

2415 (2120–2650)

–

SGA

55 (23.40)

74 (31.49)

0.74 (0.55–1.00)

DC

31

37

–

MC

24

37

–

sSGA^a

45/225 (20.0)

62/223 (27.80)

0.72 (0.51–1.01)

Gestational week(d)

259.0 (252.0–263.0)

254.0 (243.0–260.0)

–

Preterm birth^b

18 (7.66)

36 (15.32)

0.50 (0.29–0.86)

Spontaneous

15 (6.38)

32 (13.62)

0.47 (0.26–0.84)

DC

6

13

–

MC

9

19

–

Iatrogenic

3 (1.28)

4 (1.70)

0.75 (0.17–3.31)

Bleeding amount

505.66 ± 300.96

524.57 ± 445.61

–

Hemorrhage

8 (3.40)

9 (3.83)

0.89 (0.35–2.26)